PRTK RSI Chart
Last 7 days
-1.8%
Trailing 12 Months
-13.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 166.6M | 177.0M | 0 | 0 |
2022 | 138.6M | 110.7M | 116.5M | 160.3M |
2021 | 55.4M | 103.6M | 114.4M | 130.2M |
2020 | 22.9M | 30.1M | 39.9M | 46.9M |
2019 | 19.6M | 22.1M | 24.6M | 16.5M |
2018 | 0 | 14.1M | 15.6M | 17.1M |
2017 | 7.7M | 9.3M | 11.0M | 12.6M |
2016 | 0 | 0 | 0 | 6.1M |
2014 | 840.0K | 936.0K | 700.0K | 4.4M |
2013 | 7.5M | 5.4M | 3.4M | 1.3M |
2012 | 0 | 16.3M | 13.0M | 9.6M |
2011 | 12.5M | 12.5M | 10.0M | 19.7M |
2010 | 0 | 7.6M | 10.1M | 12.5M |
2009 | 0 | 0 | 0 | 5.2M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Sep 21, 2023 | peterson kristine | back to issuer | - | - | -79,000 | - |
Sep 21, 2023 | bigham michael | back to issuer | - | - | -1,358,030 | exec. chairman of the board |
Sep 21, 2023 | loh evan | back to issuer | - | - | -1,327,980 | ceo |
Sep 21, 2023 | radie robert s | back to issuer | - | - | -73,000 | - |
Sep 21, 2023 | hoffmann rolf k | back to issuer | - | - | -84,000 | - |
Sep 21, 2023 | franson timothy r | back to issuer | - | - | -72,000 | - |
Sep 21, 2023 | stein jeffrey | back to issuer | - | - | -68,625 | - |
Sep 21, 2023 | dietz thomas john | back to issuer | - | - | -69,250 | - |
Sep 21, 2023 | baylor-henry minnie | back to issuer | - | - | -59,200 | - |
Sep 21, 2023 | haskel william m. | back to issuer | - | - | -447,024 | clo, general counsel & sec. |
Which funds bought or sold PRTK recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Feb 15, 2024 | Westchester Capital Management, LLC | sold off | -100 | -8,308,540 | - | -% |
Feb 14, 2024 | MACQUARIE GROUP LTD | sold off | -100 | -5,386,000 | - | -% |
Feb 13, 2024 | Cohanzick Management, LLC | sold off | -100 | -25,558,000 | - | -% |
Oct 24, 2023 | Trellus Management Company, LLC | sold off | -100 | -280,670 | - | -% |
Oct 11, 2023 | Kathmere Capital Management, LLC | sold off | -100 | -66,300 | - | -% |
Apr 18, 2023 | ETF MANAGERS GROUP, LLC | added | 32.42 | 20,683 | 46,581 | -% |
Mar 17, 2023 | American Portfolios Advisors | unchanged | - | 10.00 | 41.00 | -% |
Feb 14, 2023 | Telemetry Investments, L.L.C. | added | 40.00 | 16,000 | 903,000 | 1.43% |
Feb 10, 2023 | Abingworth LLP | added | - | -729,085 | 1,946,920 | 0.63% |
May 16, 2022 | Parametric Portfolio Associates LLC | reduced | -9.34 | -160,000 | 241,000 | -% |
Unveiling Paratek Pharmaceuticals Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Paratek Pharmaceuticals Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 28.0% | 39,993,000 | 31,236,000 | 75,557,000 | 30,213,000 | 29,637,000 | 24,861,000 | 31,796,000 | 24,447,000 | 57,492,000 | 16,427,000 | 16,019,000 | 13,659,000 | 9,326,000 | 7,920,000 | 8,967,000 | 3,934,000 | 2,045,000 | 1,598,000 | 17,017,000 | 13,035,333 | 9,053,667 |
Cost Of Revenue | -30.0% | 4,368,000 | 6,244,000 | 10,312,000 | 4,372,000 | 4,878,000 | 3,494,000 | 4,717,500 | 4,289,000 | 9,778,000 | 2,751,000 | 2,927,000 | 2,017,000 | 2,236,000 | 1,471,000 | 1,753,000 | 958,000 | 567,000 | 206,000 | - | - | - |
Costs and Expenses | 5.0% | 49,404,000 | 47,041,000 | 78,394,000 | 46,704,000 | 42,805,000 | 38,574,000 | 59,077,000 | 38,164,000 | 43,403,000 | 30,648,000 | 33,552,000 | 29,606,000 | 27,772,000 | 31,498,000 | 32,149,000 | 32,944,000 | 32,166,000 | 34,914,000 | 37,051,000 | 29,660,000 | 27,769,000 |
S&GA Expenses | 8.3% | 36,264,000 | 33,489,000 | 53,814,500 | 33,846,000 | 30,335,000 | 27,602,000 | 43,984,000 | 25,955,000 | 27,106,000 | 22,359,000 | 24,340,500 | 20,902,000 | 20,975,000 | 23,638,000 | 21,262,000 | 23,636,000 | 20,920,000 | 23,316,000 | 25,263,000 | 13,610,000 | 12,912,000 |
EBITDA Margin | 7.2% | -0.25 | -0.27 | -0.28 | -0.34 | -0.36 | -0.29 | -0.31 | -0.68 | -0.74 | -1.37 | -1.61 | -2.72 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 18.1% | 5,287,000 | 4,476,000 | 4,558,000 | 4,536,000 | 4,546,000 | 4,479,000 | 4,389,500 | 4,367,000 | 4,344,000 | 4,307,000 | 5,265,500 | 5,178,000 | 4,971,000 | 4,826,000 | 4,626,000 | 4,560,000 | 3,991,000 | 3,226,000 | 3,191,500 | 3,383,000 | 2,904,000 |
Income Taxes | -16.4% | 51,000 | 61,000 | -543,000 | - | - | - | 600,000 | - | - | - | - | - | - | - | 301,000 | - | - | - | 502,000 | - | - |
Earnings Before Taxes | 27.8% | -14,502,000 | -20,082,000 | - | - | -17,619,000 | -17,910,000 | - | - | - | - | - | - | - | - | -27,064,000 | -32,614,000 | -33,201,000 | -35,610,000 | -22,288,500 | -32,083,000 | -29,733,000 |
EBT Margin | 5.9% | -0.36 | -0.38 | -0.40 | -0.50 | -0.53 | -0.42 | -0.45 | -0.84 | -0.93 | -1.74 | -2.06 | -3.22 | - | - | - | - | - | - | - | - | - |
Net Income | 27.8% | -14,553,000 | -20,143,000 | -7,157,000 | -20,880,000 | -17,619,000 | -17,910,000 | -32,253,000 | -18,202,000 | 9,717,000 | -18,346,000 | -25,010,000 | -20,855,000 | -23,059,000 | -27,617,000 | -27,365,000 | -32,614,000 | -33,201,000 | -35,610,000 | -22,789,000 | -32,083,000 | -29,733,000 |
Net Income Margin | 10.2% | -0.35 | -0.39 | -0.40 | -0.76 | -0.78 | -0.42 | -0.45 | -0.45 | -0.53 | -1.57 | -2.06 | -2.48 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -116.0% | -1,776,000 | 11,090,000 | -20,113,000 | -12,419,000 | -14,499,000 | -19,110,000 | -19,808,000 | 26,259,000 | -33,206,000 | -21,518,000 | -23,850,000 | -28,919,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -3.3% | 146 | 151 | 173 | 157 | 164 | 170 | 184 | 182 | 180 | 159 | 177 | 199 | 227 | 234 | 251 | 253 | 277 | 272 | 300 | 318 | 328 |
Current Assets | -5.2% | 105 | 111 | 137 | 121 | 128 | 133 | 152 | 153 | 154 | 142 | 164 | 195 | 222 | 227 | 243 | 245 | 269 | 267 | 255 | 293 | 268 |
Cash Equivalents | -5.2% | 43.00 | 45.00 | 34.00 | 27.00 | 40.00 | 49.00 | 81.00 | 111 | 75.00 | 103 | 105 | 102 | 142 | 125 | 102 | 105 | 129 | 81.00 | 47.00 | 89.00 | 56.00 |
Inventory | -18.4% | 11.00 | 14.00 | 17.00 | 21.00 | 13.00 | 13.00 | 11.00 | 9.00 | 8.00 | 14.00 | 15.00 | 19.00 | 18.00 | 13.00 | 12.00 | 9.00 | 8.00 | 2.00 | 1.00 | - | - |
Net PPE | -7.8% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Goodwill | 0% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | 2.1% | 347 | 340 | 344 | 323 | 313 | 310 | 312 | 287 | 279 | 278 | 279 | 279 | 291 | 289 | 291 | 293 | 290 | 256 | 253 | 260 | 242 |
Current Liabilities | 518.8% | 203 | 33.00 | 37.00 | 39.00 | 30.00 | 29.00 | 31.00 | 29.00 | 21.00 | 23.00 | 24.00 | 23.00 | 34.00 | 43.00 | 24.00 | 25.00 | 22.00 | 19.00 | 18.00 | 26.00 | 34.00 |
Short Term Borrowings | - | 164 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt | -63.4% | 94.00 | 258 | 257 | 258 | 257 | 256 | 254 | 253 | 253 | 251 | 250 | 251 | 252 | 240 | 261 | 260 | 260 | 229 | 229 | 229 | 203 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.00 | 21.00 | - | - | - | - | - | - | 16.00 |
LT Debt, Non Current | -63.4% | 94.00 | 258 | 257 | 258 | 257 | 256 | 254 | 253 | 253 | 251 | 250 | 251 | 252 | 240 | 261 | 260 | 260 | 229 | 229 | 229 | 203 |
Shareholder's Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.00 | 48.00 | 58.00 | 85.00 |
Retained Earnings | -1.5% | -965 | -950 | -930 | -923 | -902 | -884 | -866 | -834 | -816 | -826 | -807 | -782 | -761 | -738 | -711 | -683 | -651 | -618 | -582 | -559 | -527 |
Additional Paid-In Capital | 0.3% | 764 | 761 | 759 | 757 | 753 | 745 | 739 | 730 | 717 | 707 | 705 | 703 | 698 | 683 | 671 | 643 | 637 | 634 | 630 | 618 | 613 |
Shares Outstanding | 0% | 57.00 | 57.00 | 57.00 | 55.00 | 53.00 | 52.00 | 52.00 | 49.00 | 47.00 | 47.00 | 47.00 | 44.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | 101 | - | - | - | 315,534 | - | - | - | 231,029 | - | - | - | 127,550 | - | - | - | 294 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -116.0% | -1,776 | 11,090 | -20,113 | -12,419 | -14,499 | -19,110 | -19,808 | 26,259 | -33,206 | -21,518 | -23,850 | -28,919 | -20,329 | -30,326 | -35,530 | -28,165 | -34,594 | -35,756 | -18,985 | -20,467 | -22,675 |
Share Based Compensation | 3.7% | 2,226 | 2,146 | 1,985 | 3,979 | 3,886 | 2,469 | 4,855 | 2,879 | 5,003 | 1,599 | 2,323 | 2,401 | 2,989 | 2,535 | 3,553 | 3,824 | 3,055 | 3,863 | 12,538 | 4,084 | 4,503 |
Cashflow From Investing | 100.0% | - | -32.00 | 30,000 | - | - | -15,196 | -15,117 | 6.00 | -117 | 19,738 | 26,955 | -2,534 | 24,962 | 43,116 | 7,676 | 2,699 | 54,190 | 69,989 | -23,146 | 43,758 | -129,770 |
Cashflow From Financing | -101.8% | -565 | -280 | -2,726 | 1.00 | 4,721 | 3,097 | 4,293 | 9,436 | 4,997 | -394 | -876 | -8,945 | 12,069 | 9,092 | 24,845 | 695 | - | - | - | 9,744 | 159,291 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Net revenue | $ 39,993,000 | $ 29,637,000 | $ 71,229,000 | $ 54,498,000 |
Expenses: | ||||
Cost of product revenue | 4,368,000 | 4,878,000 | 10,612,000 | 8,372,000 |
Research and development | 8,772,000 | 7,592,000 | 16,080,000 | 15,069,000 |
Selling, general and administrative | 36,264,000 | 30,335,000 | 69,753,000 | 57,937,000 |
Total operating expenses | 49,404,000 | 42,805,000 | 96,445,000 | 81,378,000 |
Loss from operations | (9,411,000) | (13,168,000) | (25,216,000) | (26,880,000) |
Other income and expenses: | ||||
Interest income | 252,000 | 133,000 | 473,000 | 240,000 |
Interest expense | (5,287,000) | (4,546,000) | (9,763,000) | (9,025,000) |
Other (losses) gains, net | (56,000) | (38,000) | (78,000) | 138,000 |
Net loss before provision for income taxes | (14,502,000) | (17,619,000) | (34,584,000) | (35,527,000) |
Provision for income taxes | (51,000) | 0 | (111,000) | 0 |
Net loss | (14,553,000) | (17,619,000) | (34,695,000) | (35,527,000) |
Other comprehensive (loss) | ||||
Unrealized (loss) on available-for-sale securities, net of tax | 0 | (53,000) | 0 | (224,000) |
Comprehensive loss | $ (14,553,000) | $ (17,672,000) | $ (34,695,000) | $ (35,751,000) |
Net loss per common share, basic (in USD per share) | $ (0.25) | $ (0.33) | $ (0.61) | $ (0.67) |
Net loss per common share, diluted (in USD per share) | $ (0.25) | $ (0.33) | $ (0.61) | $ (0.67) |
Weighted average common stock outstanding | ||||
Weighted average number of shares outstanding, basic | 57,282,239 | 53,023,350 | 57,093,876 | 53,310,091 |
Weighted average number of shares outstanding, diluted | 57,282,239 | 53,023,350 | 57,093,876 | 53,310,091 |
Product revenue, net | ||||
Net revenue | $ 33,800,000 | $ 25,082,000 | $ 60,013,000 | $ 45,000,000 |
Government contract service revenue | ||||
Net revenue | 3,620,000 | 1,896,000 | 5,301,000 | 4,068,000 |
Government contract grant revenue | ||||
Net revenue | 1,931,000 | 2,082,000 | 4,084,000 | 4,182,000 |
Collaboration and royalty revenue | ||||
Net revenue | $ 642,000 | $ 577,000 | $ 1,831,000 | $ 1,248,000 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 42,685 | $ 34,248 |
Restricted cash | 125 | 125 |
Accounts receivable, net | 42,291 | 74,657 |
Inventories, net | 11,413 | 16,565 |
Other receivables | 220 | 3,381 |
Prepaid and other current assets | 8,493 | 7,866 |
Total current assets | 105,227 | 136,842 |
Fixed assets, net | 554 | 616 |
Goodwill | 829 | 829 |
Right-of-use assets | 1,645 | 1,782 |
Long-term inventories, net | 36,382 | 31,314 |
Other long-term assets | 1,155 | 1,155 |
Total assets | 145,792 | 172,538 |
Current liabilities | ||
Accounts payable | 2,951 | 5,308 |
Accrued expenses | 34,803 | 31,210 |
Short-term debt | 164,042 | 0 |
Other current liabilities | 823 | 870 |
Total current liabilities | 202,619 | 37,388 |
Long-term debt | 94,285 | 256,946 |
Long-term lease liabilities | 1,429 | 1,468 |
Accrued long-term compensation | 46,565 | 45,325 |
Other liabilities | 2,259 | 2,453 |
Total liabilities | 347,157 | 343,580 |
Stockholders’ deficit | ||
Undesignated preferred stock: $0.001 par value, 5,000,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common stock, $0.001 par value; 200,000,000 shares authorized; 57,282,239 shares issued and outstanding as of June 30, 2023; and 200,000,000 shares authorized; 56,651,559 shares issued and outstanding as of December 31, 2022 | 57 | 56 |
Additional paid-in capital | 763,723 | 759,351 |
Accumulated deficit | (965,145) | (930,449) |
Total stockholders’ deficit | (201,365) | (171,042) |
Total liabilities and stockholders’ deficit | $ 145,792 | $ 172,538 |